Q/C Technologies, Inc. Derivative, Gain (Loss) on Derivative, Net
Q/C Technologies, Inc. (QCLS) reported Derivative, Gain (Loss) on Derivative, Net of $81.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2026-08-12
- Q/C Technologies, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2026-06-30 was $81.00K, a 326.32% increase year-over-year.
- Q/C Technologies, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2026-03-31 was $510.00K, a 60.28% decline year-over-year.
- Q/C Technologies, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2025-06-30 was $19.00K.
- Q/C Technologies, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2025-03-31 was $1.28M.
- Q/C Technologies, Inc. derivative, gain (loss) on derivative, net for fiscal 2025 was $983.00K.
- Q/C Technologies, Inc. derivative, gain (loss) on derivative, net for fiscal 2024 was -$388.00K, a 112.56% decline from fiscal 2023.
- Q/C Technologies, Inc. derivative, gain (loss) on derivative, net for fiscal 2023 was $3.09M.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 12 month |
|---|---|---|---|
| 2026-06-30 | $81.00K 10-Q · filed 2026-08-12 | $591.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $510.00K 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | $983.00K 10-K · filed 2026-04-15 | ||
| 2025-06-30 | $19.00K 10-Q · filed 2026-08-12 | $1.30M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $1.28M 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | -$388.00K 10-K · filed 2026-04-15 | ||
| 2023-12-31 | $3.09M 10-K · filed 2025-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |